HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.

Abstract
Integrins play an important role during development, regulating cell differentiation, proliferation and survival. Here we show that knockdown of integrin subunits slows down the progression of hepatocellular carcinoma (HCC). Using nanoparticulate delivery of short interfering RNAs targeting β1 and αv integrin subunits, we downregulate all integrin receptors in hepatocytes. Short-term integrin knockdown (2 weeks) does not cause apparent structural or functional perturbations of normal liver tissue. Alterations in liver morphology accumulate on sustained integrin downregulation (7 weeks). The integrin knockdown leads to significant retardation of HCC progression, reducing proliferation and increasing tumour cell death. This tumour retardation is accompanied by reduced activation of the MET oncogene as well as expression of its mature form on the cell surface. Our data suggest that transformed proliferating cells from HCC are more sensitive to knockdown of integrins than normal quiescent hepatocytes, highlighting the potential of small interfering RNA-mediated inhibition of integrins as an anti-cancer therapeutic approach.
AuthorsRoman L Bogorad, Hao Yin, Anja Zeigerer, Hidenori Nonaka, Vera M Ruda, Marino Zerial, Daniel G Anderson, Victor Koteliansky
JournalNature communications (Nat Commun) Vol. 5 Pg. 3869 (May 21 2014) ISSN: 2041-1723 [Electronic] England
PMID24844798 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Integrin alpha Chains
  • Integrin beta Chains
  • RNA, Small Interfering
  • Proto-Oncogene Proteins c-met
Topics
  • Animals
  • Carcinoma, Hepatocellular (genetics)
  • Cell Proliferation
  • Disease Progression
  • Down-Regulation
  • Gene Knockdown Techniques
  • Hepatocytes (metabolism)
  • Integrin alpha Chains (genetics)
  • Integrin beta Chains (genetics)
  • Liver Neoplasms, Experimental (genetics)
  • Mice
  • Nanoparticles
  • Proto-Oncogene Proteins c-met (metabolism)
  • RNA, Small Interfering

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: